A reliable TB line probe assay quality control schedule
Implementing a TB lab quality control schedule for line probe assay reagents in each run means treating every batch as a traceable event, not simply recording that a test was completed. Controls must show that specimens were processed correctly, the assay remained uncontaminated, and the reagents and instrument performed as expected. Clear acceptance and invalidation rules protect patients by preventing uncertain results from entering reports.
For Australian laboratories, those rules must fit a geographically dispersed service, regulated procurement and an accreditation framework. The GLI Quality Tool provides a four-phase roadmap linked to twelve Quality Systems Essentials, covering safety, personnel, equipment, documentation, assessment and continual improvement.
Define the control strategy for each platform
Start by identifying every TB molecular assay performed in the laboratory. A line probe assay (LPA) may involve separate extraction, amplification and strip reading, while another method may combine some steps; their control lines, contamination risks and maintenance needs are not interchangeable. The SOP should name the platform, specimen types, control materials, acceptance criteria and authorised report wording.
Assign responsibility clearly. The operator checks readiness and performs the run, a second competent staff member verifies critical results where required, and the QC lead reviews exceptions, trends and changes. Link operator competency and authorisation records to the quality management system without duplicating information that belongs in the run sheet.
Layer the schedule into controls for every run, verification for each new reagent lot, periodic proficiency assessment and trend review. External quality assessment is not a substitute for internal controls: it examines the wider process at program-defined intervals, whereas internal controls protect the current run. The GLI laboratory checklists can support this structure without replacing manufacturer instructions or national program requirements.
Prepare reagents, specimens and the work area
On receipt, record the manufacturer, catalogue number, reagent and control lot, quantity, receipt date and use-by date. Store each item as specified, with temperature monitoring where required. A reagent that has arrived warm, frozen by mistake or stored outside its permitted range should be quarantined and assessed rather than used simply because its packaging appears intact.
Australia’s size makes logistics part of quality control. A specimen or reagent may move from a regional collection point such as Darwin or Alice Springs to a metropolitan specialist laboratory by air freight or overnight courier. Record transport method and time, inspect packaging, and apply stability and rejection rules. If a temperature excursion cannot be excluded, seek an evidence-based disposition from the supplier or technical service.
Prepare the workspace before opening reaction tubes or ampoules. Use unidirectional movement from clean preparation to amplified-product areas, separate pipettes and equipment, and follow the site biosafety risk assessment and product instructions for protective equipment and cabinet use. Good housekeeping is part of QC because contamination introduced during setup can invalidate an otherwise clean run.
Complete a structured pre-run readiness check
Open the run record before testing starts. Confirm that the request and specimen meet acceptance criteria, the intended assay is appropriate, and any confirmatory pathway for rifampicin resistance or other markers matches the program algorithm. Check sample integrity, haemolysis, transport delay and inhibition concerns recorded during primary testing. A questionable specimen follows the SOP rather than being made acceptable by an apparently normal control.
Verify the analyser or reader. Review recent maintenance, cleaning, calibration and service records, confirm required consumables are available, and remove equipment or reagents with unresolved deviation labels. Where the platform monitors room conditions, check that readings are within its validated operating range and document any out-of-range alert.
Stage the controls required by the method. Depending on the validated assay, these may include a positive control, a negative control and an internal sample-processing control, alongside the control line built into each strip or reaction. Bring controls to the required storage condition, use a fresh aliquot where specified, and verify their identity and labelling. Never improvise a substitute or transfer acceptance rules from another manufacturer’s assay.
Apply objective run acceptance and invalidation rules
Give every control a predetermined pass or fail result. Where required, the positive control must produce the expected pattern, the negative control no signal, and an internal control must meet the kit’s processing and inhibition criteria. Assess control-line intensity according to the manufacturer or validated imaging procedure; staff should not interpret a faint line informally or compensate for a weak result through experience.
A failed control invalidates the affected results, not merely the control itself. Stop reporting, place affected material on hold, and investigate evidence-based causes such as expired reagents, incorrect storage, missed maintenance, pipetting error, control degradation, sample inhibition or contamination. The record must separate the observed failure from the suspected cause.
Repeat testing only after choosing a corrective action that addresses the likely cause. Use fresh controls and, where relevant, fresh reagent aliquots; repeat affected samples rather than the whole batch if the validated procedure permits. Record original and repeat results and document any incident, supplier notification or corrective and preventive action. In Australian laboratory handover, staff may say a batch is “signed off” or a run is “rejected”, but the record must show the objective evidence behind that decision.
Maintain records that make each run auditable
Use a unique run identifier that links specimens, controls, instrument output, reagent lots and staff actions. Define retention, amendment rights and traceability in the quality management system. Back up electronic records and reconcile paper run sheets with instrument files so changes remain attributable.
Record these items before the run:
- Run identifier, date, operator and assay or module
- Reagent and control names, lots and use-by dates
- Storage and transport temperature checks or excursion status
- Instrument maintenance, calibration and environmental status
Complete these entries after the run:
- Control identities, lot numbers, results and acceptance decision
- Patient-test validity, repeat action and report-release status
- Deviations, quarantine decisions, investigations and notifications
- Consumable use, remaining stock and the next scheduled verification
The additional checklist resources offer prompts for aligning run sheets with equipment, safety and document-control needs. Australian laboratories commonly work to NATA accreditation requirements based on ISO 15189 and the applicable Australian standard, so traceable competence, authorised procedures and documented corrective action matter as much as the immediate strip result.
Build a layered verification schedule
A practical schedule separates checks that protect every run from checks triggered by change. Routine controls remain brief and consistent, while expanded verification provides confidence after a new lot, an instrument move, a storage excursion or a shift in testing volume. Assign an owner and due date to each activity.
| Activity | Minimum frequency | Expanded check or trigger | Required decision |
|---|---|---|---|
| Patient and specimen readiness | Every request | Transport delay, poor integrity or inhibition concern | Recollect or reprocess under the SOP |
| Internal control and strip control line | Every reaction | Major procedural or platform change | Invalidate and repeat affected result |
| Negative control | Each extraction batch or validated run frequency | Contamination signal or layout change | Hold the run and investigate contamination |
| Positive control | Each run when required by the kit and SOP | Every new lot and after instrument service | Reject the run; check reagents and instrument |
| New-lot verification | Before first use of every lot | Supplier, shipment or storage-condition change | Quarantine lot and complete authorised checks |
| Proficiency assessment | At program-defined intervals | Serious deviation or adverse trend | Review findings and open corrective actions |
Proficiency testing should follow the schedule set by the relevant program and use an accredited or otherwise suitable provider. It adds independent assessment but does not replace daily controls. Before releasing a new lot, apply the validated verification plan, which may include parallel testing against the current lot and representative results covering positive, negative and borderline patterns.
Procurement is a common source of change in Australia. Tender decisions and imported supply routes can alter packaging, shipment conditions, lead times or inventory. Compare landed cost, freight, storage capacity, expiry risk and technical support, but introduce a different product only after compatibility, regulatory status and local verification are confirmed. Retain verification samples where policy permits for future investigations.
Review trends and embed continual improvement
Review control failures, invalid-run rates, repeat rates, reagent wastage and turnaround time at fixed intervals, such as weekly for operations and monthly for the QC lead. Break results down by lot, operator, instrument and day so clustered patterns become visible. Record trends even when every run passes, because stable data support formal decisions about changing control frequency.
Use deviations to improve the system rather than assign blame. Confirm that corrective and preventive actions address root causes, have named owners and include checks for effectiveness. Reassess the schedule after method changes, new staff, equipment moves, supplier changes or external assessment findings, and retain superseded versions for the required period. Competency observations should include the readiness check, control interpretation and invalid-run workflow.
Use the GLI feedback form for de-identified comments on checklist clarity and field usability. Assign a QC lead today, place the approved run checklist beside each instrument, brief every operator and schedule the first monthly trend review. This creates an auditable starting point and keeps the routine focused on safe, reliable TB laboratory results.